This two-day conference offers an exclusive forum for executives and entrepreneurs from the neurotechnology device and neuropharmaceutical industries to interact with investors, technologists, and potential partners who are actively working to grow this market. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neuroscience industry and the investment community.

Sessions will cover a range of technologies and market segments in the neuro space, including neuromodulation, neural prostheses, neuropharmaceuticals, cell-based therapies, neurodiagnostics, and neurostimulation. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as cochlear implants, stroke rehabilitation devices, implanted pain stimulators, neural-computer interfaces, and advanced brain sensing technologies.

The first day of the conference features four intensive courses for neuro professionals, one devoted to fundamentals of neuro technology, another to neurotechnology market fundamentals, a third to the current status of neuropharmaceuticals, and a fourth to obtaining venture capital financing. The day concludes with a session devoted to neurological disorders and available therapies for those disorders, plus an interative session with clinicians and users.

The second day of the conference features panel discussions on key issues affecting the industry, such as reimbursement issues, licensing, and other commercialization factors. The second day also includes a unique session devoted to analyzing commercial failures in the neurotechnology device and neuropharmaceutical industries, conducted by two of the most knowledgeable industry editors in the field, Harry Tracy of NeuroInvestment and James Cavuoto of Neurotech Business Report.

The forum will also feature presentations from several early-stage neurotechnology and neuropharmaceutical firms covering a range of product and technology areas. The conference will wrap up with a panel discussion featuring representatives of some of the leading venture capital firms active in the neuro space. The panelists will discuss critical issues such as the relative strengths and weaknesses of devices and bio/pharma approaches to neurological disorders, the current investment climate in the neuro space, and factors in obtaining funding for neuroscience startups.

A preliminary agenda for this year's event is available by clicking the link on the left. For a report on events and attendance at last year's event, click here:

http://www.neurotechreports.com/pages/NLF08report.html

For information on sponsorship opportunities, visit this link:
http://www.neurotechreports.com/pages/nlfsponsorship.html